Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	> 1000
2008
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2020	0	3.749.669	0		1
2010	5.982.600	0	1.247.200	1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
APEIRON BIOLOGICS	1
BEACTICA AB	1
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA	1
INSERM TRANSFERT	1
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE	1
INSTITUTE OF ORGANIC CHEMISTRY WITH CENTRE OF PHYTOCHEMISTRY BULGARIAN ACADEMY OF SCIENCES	1
JLP HEALTH	1
JUSTUS LIEBIG UNIVERSITAET GIESSEN	1
NATIONAL VETERINARY INSTITUTE	1
PHARMACELSUS	1
PIKE PHARMA	1
STEMCELL TECHNOLOGIES UK	1
STICHTING VU	1
UNIVERSITA DEGLI STUDI DI SIENA	1
UNIVERSITAETSKLINIKUM FREIBURG	1
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG	1
VILNIUS UNIVERSITY	1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2020-08-01	Modern approaches for developing antivirals against SARS-CoV 2	MAD-CoV 2	participant	3.749.669	9
2010-10-01	Development of novel antiviral drugs against Influenza	FLUCURE	coordinator	5.982.600	10

Alias institution names:

VIRONOVA AB

VIRONOVA AB - Sweden